Panacea Biotec Limited (NSE:PANACEABIO)
India · Delayed Price · Currency is INR 441.00
+1.25 (0.28%)
Oct 24, 2025, 3:29 PM IST
Panacea Biotec Market Cap
Panacea Biotec has a market cap or net worth of 27 billion as of October 24, 2025. Its market cap has increased by 51.04% in one year.
Market Cap
27.00B
Enterprise Value
26.08B
Revenue
6.10B
Ranking
n/a
PE Ratio
234.93
Stock Price
441.00
Market Cap Chart
Since April 1, 2002, Panacea Biotec's market cap has increased from 21.08B to 27.00B, an increase of 28.11%. That is a compound annual growth rate of 1.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 27.00B | 5.30% |
| Dec 31, 2024 | 25.64B | 149.32% |
| Dec 29, 2023 | 10.28B | 18.20% |
| Dec 30, 2022 | 8.70B | -28.49% |
| Dec 31, 2021 | 12.17B | -17.07% |
| Dec 31, 2020 | 14.67B | 82.44% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.08T |
| Divi's Laboratories | 1.75T |
| Cipla | 1.28T |
| Apollo Hospitals Enterprise | 1.13T |
| Zydus Lifesciences | 1.01T |
| Mankind Pharma | 1.00T |
| Fortis Healthcare | 783.12B |
| Alkem Laboratories | 662.99B |